US2009228059A1PendingUtilityA1
Method and device for lymphatic system monitoring
Est. expiryJun 6, 2026(expired)· nominal 20-yr term from priority
A61B 5/076A61B 5/14546A61B 5/03A61B 5/418A61N 1/3627A61B 5/0031A61B 5/4839A61N 1/36514A61B 5/415
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A device and method are disclosed for physiological monitoring of the lymphatic system. An implantable device is configured with a lymphatic sensor disposed in a lymphatic vessel for sensing pressure, flow, and/or the concentration of particular markers within the vessel. The device may be further configured to deliver appropriate therapy in accordance with the lymphatic monitoring.
Claims
exact text as granted — not AI-modified1 . A device, comprising:
monitoring and therapy circuitry contained within an implantable housing; a lead electrically connected to the monitoring circuitry that is adapted for implantation into a lymphatic vessel, the lead having a lymphatic sensor incorporated therein for sensing a physiological parameter related to lymphatic function; a controller interfaced to the therapy circuitry and interfaced to the monitoring circuitry for processing sensing signals generated by the lymphatic sensor; wherein the controller is programmed to modify the delivery of therapy when edema is detected from the lymphatic sensor signals.
2 . The device of claim 1 wherein the lymphatic sensor is a pressure sensor.
3 . The device of claim 1 wherein the lymphatic sensor is a flow sensor.
4 . The device of claim 1 wherein the lymphatic sensor is a chemo-sensor for generating a voltage proportional to the concentration of a particular chemical species in the lymphatic fluid.
5 . The device of claim 1 further comprising a telemetry transceiver interfaced to the controller for enabling wireless communication with the controller.
6 . The device of claim 5 wherein the controller is programmed to transmit an alarm message via the telemetry transceiver if a value sensed by the lymphatic sensor reaches a specified limit value.
7 . The device of claim 1 wherein the therapy circuitry comprises:
cardiac pacing circuitry, including pulse generation circuitry and cardiac sensing circuitry; one or more leads with pacing/sensing electrodes electrically connected to the cardiac pacing circuitry; and, wherein the controller is programmed to deliver bradycardia pacing therapy based upon sensing signals generated by the lymphatic sensor.
8 . The device of claim 1 wherein the therapy circuitry comprises:
pulse generation circuitry; one or more leads with electrodes electrically connected to the pulse generation circuitry for delivering neural stimulation; and, wherein the controller is programmed to deliver neural stimulation therapy based upon sensing signals generated by the lymphatic sensor.
9 . The device of claim 1 wherein the therapy circuitry comprises:
a drug delivery device actuated by the therapy circuitry; and, wherein the controller is programmed to deliver medication based upon sensing signals generated by the lymphatic sensor.
10 . The device of claim 1 wherein the therapy circuitry comprises:
cardiac pacing circuitry, including pulse generation circuitry and cardiac sensing circuitry; one or more leads with pacing/sensing electrodes electrically connected to the cardiac pacing circuitry; and, wherein the controller is programmed to deliver cardiac resynchronization therapy based upon sensing signals generated by the lymphatic sensor.
11 . The device of claim 10 wherein the controller is programmed to initiate, or increase, the delivery of cardiac resynchronization therapy upon sensing a lymphatic flow or pressure value indicative of edema.
12 . The device of claim 10 wherein the controller is programmed to adjust one or more cardiac resynchronization parameters upon sensing a lymphatic flow or pressure value indicative of edema.Join the waitlist — get patent alerts
Track US2009228059A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.